ZUSAMMENSETZUNGEN

European patent · EP2488022 · In force

Register entry

Publication number
EP2488022
Application number
EP10824162
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 15, 2010
Published
Aug 22, 2012
Granted
Jan 10, 2018
Protection ends at the latest
Oct 14, 2030
Next annual fee due
Oct 31, 2026
IPC classes
A61K 9/08 (2006.01)
A61K 47/34 (2017.01)
A61K 47/14 (2017.01)
A61K 9/107 (2006.01)
A23D 7/015 (2006.01)
A23L 33/12 (2016.01)
Priority
US 267697 P 08.12.2009
US 252310 P 16.10.2009
PCT application
PCT/US2010/052840 15.10.2010
PCT publication
WO2011/047259 21.04.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Jan 10, 2018

    Granted

    Published in Swissreg on 10.01.2018

  6. Jan 10, 2018

    Agent entered

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 10.01.2018

Parties

Holder

Mochida Pharmaceutical Co., Ltd.

7 Yotsuya 1-chome Shinjuku-ku, Tokyo 160-8515, JP

Agent

Bovard AG

BOVARD AG Patent- und Markenanwälte

Optingenstrasse 16, 3013 Bern

Inventor

ABU-BAKER, Omar, Abdelfattah

Collegeville, PA 19426, US

MACKENZIE, Donald, Colin

King of Prussia, PA 19406, US

PAN, Rennan

Collegeville, PA 19426, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.